Search results
Asian Americans are 7% of population but account for 58% of hepatitis B cases. Experts call for more...
NBC News via Yahoo News· 2 hours agoNational health care officials are sounding the alarm this month on the disproportionate impact of ...
Dynavax Technologies (DVAX) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 10 hours agoThe first quarter of 2024 saw continued year-over-year growth in quarterly HEPLISAV-B net product...
Nearly 2,000 people unaware they have hepatitis C from infected blood
The Telegraph via Yahoo News· 7 hours agoThe scandal saw thousands of people in the UK in the 1970s and 1980s given blood transfusions or...
Namibia reaches key milestone in eliminating mother-to-child transmission of HIV and hepatitis B
World Health Organization· 3 days agoWindhoek – Namibia has become the first country in Africa – and the first high-burden country in the world - to reach a significant milestone on the path towards eliminating vertical mother-to-child ...
Researchers may have found an Achilles heel for Hepatitis B
Medical Xpress· 1 day agoMost treatments try to inhibit the virus's polymerase (pol) protein. Now, researchers from the lab of Rockefeller's Charles M. Rice have revealed never-before-seen mechanisms that may lead to ...
$27 million jury award in Bucks County tops previous record: report
Bucks County Courier Times via Yahoo Finance· 7 hours agoThe case involved five scientists employed at Sigmapharm Laboratories, which makes drugs to treat...
Earnings call: Vir Biotechnology reports Q1 2024 financials, pipeline progress
Investing.com· 6 days agoNoteworthy developments include promising preliminary data from its hepatitis B program and the...
Dynavax Technologies Corp (DVAX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue ...
GuruFocus.com via Yahoo Finance· 9 hours agoExplore the key financial outcomes and strategic insights from Dynavax Technologies Corp's first quarter of 2024, including significant revenue growth and enhanced gross margins.
Earnings call: Arbutus Biopharma outlines progress in HBV clinical trials By Investing.com
Investing.com· 7 days agoThe company, which is developing treatments for chronic hepatitis B, announced the retirement of its...
Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 11 hours agoStrengths Robust Product Portfolio and Pipeline: Gilead Sciences Inc's strength lies in its diverse...